STOCK TITAN

Cadre Holdings (NYSE: CDRE) insider files Form 144 to sell 24,000 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cadre Holdings insider files to sell additional shares under Rule 144. A holder plans to sell 24,000 shares of Cadre Holdings common stock through UBS Financial Services on the NYSE, with an aggregate market value of approximately $1,031,309.14. These shares were acquired as restricted stock units from the issuer on March 18, 2024.

As context, 40,663,844 shares of Cadre Holdings common stock were outstanding at the time of this notice. Over the past three months, the same seller completed multiple open-market sales, including a 27,370‑share transaction on November 13, 2025 that generated gross proceeds of $1,193,840. The seller represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for CDRE disclose about insider stock sales?

The notice states that a holder intends to sell 24,000 shares of Cadre Holdings (CDRE) common stock under Rule 144 on the NYSE through UBS Financial Services, with an aggregate market value of about $1,031,309.14.

How many Cadre Holdings (CDRE) shares are outstanding in this Form 144?

The filing reports that 40,663,844 shares of Cadre Holdings common stock were outstanding when the notice was prepared.

How were the 24,000 Cadre Holdings (CDRE) shares being sold acquired?

The 24,000 shares planned for sale were acquired on March 18, 2024 as restricted stock units (RSUs) from the issuer.

What prior Cadre Holdings (CDRE) stock sales by this seller are disclosed?

Over the past three months, the seller completed several sales of Cadre Holdings common shares, including a 27,370‑share sale on November 13, 2025 that generated gross proceeds of $1,193,840.

Which broker is handling the planned Cadre Holdings (CDRE) sale and on which exchange?

The planned sale of 24,000 Cadre Holdings common shares is to be executed through UBS Financial Services Inc. on the NYSE.

>What representation does the seller make about Cadre Holdings (CDRE)?

By signing the notice, the seller represents that they do not know of any material adverse information about Cadre Holdings’ current or prospective operations that has not been publicly disclosed.
Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.70B
29.02M
29.12%
69.63%
4.85%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE